Arch Biopartners Inc. (TSXV:ARCH)

Arch Biopartners Ratios and Metrics

Market cap in millions CAD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 12, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	47	85	114	69	187	107
Market Cap Growth	-61.07%	-25.03%	65.53%	-63.23%	75.09%	27.95%
Enterprise Value	50	88	119	74	191	112
Last Close Price	0.73	1.28	1.77	1.09	3.01	1.71
PS Ratio	299.97	308.46	53.51	34.58	193.39	27.41
PB Ratio	-13.18	-21.93	-26.11	-12.45	-41.73	-27.44
P/OCF Ratio	-	-	-	-	389.08	-
EV/Sales Ratio	-	317.72	55.97	37.12	197.59	28.88
Debt / Equity Ratio	-0.73	-0.73	-0.64	-0.91	-0.99	-1.33
Net Debt / Equity Ratio	-0.73	-0.73	-0.64	-0.76	-0.87	-1.22
Asset Turnover	0.57	0.53	2.01	2.21	0.59	2.28
Quick Ratio	0.00	0.02	0.17	0.19	0.21	0.83
Current Ratio	0.01	0.03	0.18	0.20	0.22	0.84
Return on Assets (ROA)	-524.03%	-136.33%	-205.03%	-201.92%	-37.89%	-30.04%
Return on Capital Employed (ROCE)	65.10%	29.20%	79.50%	60.30%	46.20%	157.30%
Earnings Yield	-5.69%	-1.82%	-3.45%	-4.85%	-0.76%	-1.10%
Buyback Yield / Dilution	-2.96%	-3.51%	-1.46%	-0.49%	-1.36%	-2.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.